NP002

· Neuraltus Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NP002, covering 2011-10-05 to 2011-10-05. Get the full timeline:

Most recent: Clinical Trial Update: Study of NP002 in Subjects With Idiopathic Parkinson's Disease to Treat Dyskinesias Due to Levodopa Therapy [Phase 1, Phase 2]

See pricing